The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset

Overview of attention for article published in Acta Neuropathologica, March 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet
patent: 2 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 103 Dimensions

Readers on

mendeley: 88 Mendeley

Summary News Patents Research highlights Dimensions citations

So far, Altmetric has seen 1 news story.

Antibody Against α-Synuclein Looks Safe In Phase 1

Alzforum, 31 Mar 2015

Treatments targeting the main pathological protein of Parkinson’s disease are moving toward the clinic, with two…